Cynosure Expands Portfolio with New Acquisition

Cynosure seems to be doing just fine after it was divested from Hologic in 2019. The medical aesthetics company is even getting involved in some acquisitions.The Westford, MA-based company said on Friday it entered into an agreement to acquire the MyEllevate Surgical Suture System, expanding the company’s portfolio of minimally invasive facial rejuvenation solutions.

Source: Cynosure Expands Portfolio with New Acquisition

Insulin-injection device maker CeQur brings in $115M to launch J&J-licensed product 

Marlborough-based CeQur, a maker of insulin delivery devices, has raised $115 million in capital as it gears up to launch its wearable insulin injector later this year.

Source: Insulin-injection device maker CeQur brings in $115M to launch J&J-licensed product – Boston Business Journal

Clinical Trial For DEKA Dialysis Device Being Considered At Manchester VA

A new public-private partnership may bring the clinical trial of a dialysis device to the Manchester VA. The device, the CVS Kidney Care’s HemoCare Hemodialysis System developed by DEKA research in Manchester, would allow dialysis patients to complete the process at home.

Source: Clinical Trial For DEKA Dialysis Device Being Considered At Manchester VA | New Hampshire Public Radio

Abbott’s Fast Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization

ABBOTT PARK, Ill., Aug. 26, 2020 /PRNewswire/ — Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection. Abbott will sell this test for $5. It is highly portable (about the size of a credit card), affordable and provides results in 15 minutes. BinaxNOW uses proven Abbott lateral flow technology, making it a reliable and familiar format for frequent mass testing through their healthcare provider. With no equipment required, the device will be an important tool to manage risk by quickly identifying infectious people so they don’t spread the disease to others.

Source: Abbott’s Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return to Daily Life; Ramping Production to 50 Million Tests a Month – Aug 26, 2020

Thermo Fisher’s COVID-19 Test Could Have Inaccurate Results

FDA warned earlier this week that Thermo Fisher Scientific’s TaqPath test could have a risk of false results. This follows the Waltham, MA-based company exiting its bid to acquire Qiagen for $12.5 billion.

Source: Thermo Fisher’s COVID-19 Test Could Have Inaccurate Results

Homodeus Awaits COVID Home Testing Approval

Many of us have seen and even felt what it’s like to have a test for COVID-19. One Connecticut medical science company saw the national struggle to make tests available, so they took on the challenge.

Source: Guilford Company Awaits COVID Home Testing Approval

COVID-19: FDA Opens Door for Rapid At-Home Testing

FDA opens door to rapid, at-home screening for COVID-19

The Food and Drug Administration on Wednesday opened the door to COVID-19 testing that could be fast, cheap, and handled entirely at home — if companies don’t find the rules too burdensome.

Source: FDA opens door to rapid, at-home screening for COVID-19

Abbott’s COVID-19 tests did the heavy lifting in Q2

Abbott’s second-quarter earnings showed a mixed bag with pandemic disruptions on the medical device side of the business, and sales of COVID-19 tests driving growth for the diagnostic side.

Source: Abbott’s COVID-19 tests did the heavy lifting in Q2

A Medical Aesthetic Device Case Study: Candela

Candela is driven by an unwavering focus on quality and innovation. For more than 50 years, the company has pioneered breakthroughs using energy-based laser devices for treating a broad range of conditions, from hair removal and wrinkle reduction to traumatic scarring involving wounded warriors and burn victims.

Source: A Medical Aesthetic Device Case Study: Candela | Jabil

How Speed Up the Healthcare Product Development Cycle 

Healthcare worldwide is at an exciting inflection point. On the one hand is reactive medicine, which to a large extent describes the profile of the existing system – you get sick, visit your healthcare provider, get treated and go home.

Source: 3 Ways to Speed Up the Healthcare Product Development Cycle | Jabil